Stem Cells, Vol 13, 167-174, Copyright © 1995 by AlphaMed Press

ORIGINAL ARTICLES

CD34+ cell expansion and expression of lineage markers during liquid culture of human progenitor cells

MK Warren, WL Rose, LD Beall and J Cone
Otsuka America Pharmaceutical, Inc., Rockville, Maryland 20850, USA.

A 96-well-based suspension culture system for human hematopoietic progenitor cells has been developed to monitor the commitment and differentiation of CD34+ cells to specific lineages and the maintenance and expansion of CD34+ cells in vitro. The expression of maturation and lineage markers on the cells in culture was measured by enzyme-linked immunosorbent assay (ELISA). CD34+ cells were isolated from umbilical cord blood and fetal liver (90% purity) and were grown in liquid culture in 96-well plates for 10 days. The cells were then fixed with a glutaraldehyde-paraformaldehyde mixture, attaching the cells firmly to the plastic. An ELISA was performed, using appropriate primary antibodies directed against cell surface markers. The expression of four different lineage markers was measured: CD14 (monocyte), CD15 (neutrophil), platelet glycoprotein (GP) IIb/IIIa (CD41a, megakaryocyte) and glycophorin A (erythroid). The two-growth factor combination of interleukin 3 (IL-3) and stem cell factor (SCF) stimulated expression of CD14, CD15 and GP IIb/IIIa. Lineage-restricted growth factors such as erythropoietin (EPO), in combination with SCF, stimulated expression of glycophorin A. The three-factor combination of IL-3, SCF and EPO stimulated expression of all four lineage markers. Other multiple growth factor combinations all stimulated myeloid and megakaryocyte growth, as measured by ELISA and flow cytometry, but erythroid growth was present only when EPO was included in the growth factor mixture. In serum-free medium or plasma-containing medium, CD14 expression was markedly reduced, whereas glycophorin A expression was greatly elevated in serum-free medium.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. Shao, C. C. White, M. J. Dabrowski, T. J. Kavanagh, M. L. Eckert, and E. P. Gallagher The Role of Mitochondrial and Oxidative Injury in BDE 47 Toxicity to Human Fetal Liver Hematopoietic Stem Cells Toxicol. Sci., January 1, 2008; 101(1): 81 - 90. [Abstract] [Full Text] [PDF]

				Y. REISNER, H. GUR, S. REICH-ZELIGER, M. F. MARTELLI, and E. BACHAR-LUSTIG Hematopoietic Stem Cell Transplantation across Major Genetic Barriers: Tolerance Induction by Megadose CD34 Cells and Other Veto Cells Ann. N.Y. Acad. Sci., May 1, 2003; 996(1): 72 - 79. [Abstract] [Full Text] [PDF]

				N. Inaba, T. Hiruma, A. Togayachi, H. Iwasaki, X.-H. Wang, Y. Furukawa, R. Sumi, T. Kudo, K. Fujimura, T. Iwai, et al. A novel I-branching beta -1,6-N-acetylglucosaminyltransferase involved in human blood group I antigen expression Blood, April 1, 2003; 101(7): 2870 - 2876. [Abstract] [Full Text] [PDF]

				H. Gur, R. Krauthgamer, A. Berrebi, T. Klein, A. Nagler, A. Tabilio, M. F. Martelli, and Y. Reisner Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34+ cells Blood, May 13, 2002; 99(11): 4174 - 4181. [Abstract] [Full Text] [PDF]

				D. E. Greenwalt, J. Szabo, and I. Manchel High Throughput Cell-Based Assay of Hematopoietic Progenitor Differentiation J Biomol Screen, December 1, 2001; 6(6): 383 - 392. [Abstract] [PDF]

				M. E. Merino, F. Navid, B. L. Christensen, J. A. Toretsky, L. J. Helman, N.-K. V. Cheung, and C. L. Mackall Immunomagnetic Purging of Ewing's Sarcoma From Blood and Bone Marrow: Quantitation by Real-Time Polymerase Chain Reaction J. Clin. Oncol., August 15, 2001; 19(16): 3649 - 3659. [Abstract] [Full Text] [PDF]

				G. N. Schwartz, U. Kammula, M. K. Warren, M. K. Park, X.-Y. Yan, F. M. Marincola, and R. E. Gress Thrombopoietin and Chemokine mRNA Expression in Patient Post-Chemotherapy and In Vitro Cytokine-Treated Marrow Stromal Cell Layers Stem Cells, September 1, 2000; 18(5): 331 - 342. [Abstract] [Full Text]

				D. S. Pereira, C. Dorrell, C. Y. Ito, O. I. Gan, B. Murdoch, V. N. Rao, J.-P. Zou, E. S. P. Reddy, and J. E. Dick Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells PNAS, July 7, 1998; 95(14): 8239 - 8244. [Abstract] [Full Text] [PDF]

				F. Norol, N. Vitrat, E. Cramer, J. Guichard, S. A. Burstein, W. Vainchenker, and N. Debili Effects of Cytokines on Platelet Production From Blood and Marrow CD34+ Cells Blood, February 1, 1998; 91(3): 830 - 843. [Abstract] [Full Text] [PDF]

				J. A. LaIuppa, E. T. Papoutsakis, and W. M. Miller Evaluation of Cytokines for Expansion of the Megakaryocyte and Granulocyte Lineages Stem Cells, May 1, 1997; 15(3): 198 - 206. [Abstract] [Full Text]

				G. Schwartz, M. Warren, K Sakano, J. Szabo, S. Kessler, A Pashapour, R. Gress, and J. Perdue Comparative effects of insulin-like growth factor II (IGF-II) and IGF- II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesis Stem Cells, May 1, 1996; 14(3): 337 - 350. [Abstract]